Skip to content

Research on the Role of cutaneous neural dysfunction in the repair of diabetic wounds

Research on the Role of cutaneous neural dysfunction in the repair of diabetic wounds

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500109991
Enrollment
Unknown
Registered
2025-09-28
Start date
2025-10-01
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

Healthy Wound Group:None

Sponsors

The affiliated hospital of southwest medical university
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Healthy skin / Acute wound group: Non-diabetic patients with acute wounds Age 18-85 years. Require surgical treatment for an acute wound (involving intraoperative debridement). The acute wound has been present for less than 2 weeks. No history of diabetes mellitus or other systemic diseases. 2. Diabetic skin / Wound group: Patients with refractory diabetic wounds Age 18-85 years. Meet the WHO diagnostic criteria for diabetes mellitus (fasting blood glucose >= 7.0 mmol/L or 2-hour postprandial blood glucose >= 11.1 mmol/L). Require surgical treatment for a refractory wound (involving intraoperative debridement). The wound has failed to heal for more than 4 weeks. Absence of complications such as skin infection or autoimmune diseases.

Exclusion criteria

Exclusion criteria: 1. Patients with comorbid malignancies, or severe dysfunction of vital organs such as the heart, liver, or kidneys. 2. Patients who have received immunosuppressant or glucocorticoid therapy within the past 3 months. 3. Patients with skin infections, ulcers, or other dermatological conditions (excluding the acute wounds in the Healthy skin/Acute wound group). 4. Pregnant or lactating women. 5. Patients with psychiatric disorders or those unable to cooperate with sample provision and related data collection.

Design outcomes

Primary

MeasureTime frame
Metabolomic and transcriptomic analyses of neural function;

Countries

China

Contacts

Public ContactJunchao Dai

The affiliated hospital of southwest medical university

563957438@qq.com+86 159 0826 9859

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026